Insider Trading activities of Pharmion Corp insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pharmion Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pharmion Corp since year 2005. Table 2 shows the detailed insider transactions of Pharmion Corp since 2005. The reporting company's ticker symbol is PHRM. The reporting company's CIK number is 1203866.
The total value of stock buying since 2005 is $21,312,958.
The total value of stock sales since 2005 is $4,875,933.
The total value of stock option exercises since 2005 is $3,312,225.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Pharmion Corp (PHRM).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2008-03 0 $0 0 $0 132,443 $2,332,795
2007-12 0 $0 0 $0 7,037 $450,001
2007-11 0 $0 0 $0 32,813 $193,268
2007-09 0 $0 0 $0 1,250 $51,262
2007-08 0 $0 83,840 $3,445,437 60,000 $284,899
2006-08 1,300 $22,867 0 $0 0 $0
2006-06 46,300 $818,414 0 $0 0 $0
2006-05 1,012,000 $19,332,599 0 $0 0 $0
2006-03 42,813 $729,238 21,666 $366,112 0 $0
2006-02 1,500 $23,250 0 $0 0 $0
2005-12 0 $0 7,650 $141,035 0 $0
2005-11 0 $0 50,000 $923,349 0 $0
2005-10 22,000 $386,590 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Pharmion Corp insiders (PHRM)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-03-07 Allen Andrew R (Chief Medical Officer, EVP) Option Ex 3,800 72.49 275,462
2008-03-07 Dupont Steven N (EVP and General Counsel) Option Ex 1,650 72.49 119,608
2008-03-07 Cosgrave Michael (EVP, Global Commercial) Option Ex 3,750 72.49 271,837
2008-03-07 Ivers-read Gillian C (EVP, Development Operations) Option Ex 2,100 72.49 152,229
2008-03-07 Mahaffy Patrick J (CEO, President) Option Ex 9,375 72.49 679,593
2008-03-07 Mast Erle T (EVP, CFO) Option Ex 2,625 72.49 190,286
2008-03-04 Mahaffy Patrick J (CEO, President) Option Ex 46,330 11.25 521,351
2008-03-03 Mast Erle T (EVP, CFO) Option Ex 62,500 1.60 100,000
2008-03-01 Allen Andrew R (Chief Medical Officer, EVP) Option Ex 313 71.66 22,429
2007-12-06 Allen Andrew R (Chief Medical Officer, EVP) Option Ex 225 63.98 14,395
2007-12-06 Dupont Steven N (Executive VP, General Counsel) Option Ex 550 63.98 35,189
2007-12-06 Cosgrave Michael (EVP, Global Commercial) Option Ex 1,250 63.98 79,975
2007-12-06 Ivers-read Gillian C (EVP, Development Operations) Option Ex 700 63.98 44,786
2007-12-06 Mahaffy Patrick J (CEO, President) Option Ex 3,125 63.98 199,937
2007-12-06 Mast Erle T (EVP, CFO) Option Ex 875 63.98 55,982
2007-12-01 Allen Andrew R (Chief Medical Officer, EVP) Option Ex 312 63.26 19,737
2007-11-08 Ivers-read Gillian C (EVP, Development Operations) Option Ex 32,813 5.89 193,268
2007-09-01 Allen Andrew R (Chief Medical Officer, EVP) Option Ex 1,250 41.01 51,262
2007-08-24 Ivers-read Gillian C (EVP, Development Operations) Sale 23,840 38.53 918,507
2007-08-06 Dupont Steven N (VP, General Counsel) Sale 10,000 42.69 426,930
2007-08-06 Dupont Steven N (VP, General Counsel) Option Ex 10,000 18.49 184,899
2007-08-06 Mast Erle T (EVP, CFO) Sale 50,000 42.00 2,100,000
2007-08-06 Mast Erle T (EVP, CFO) Option Ex 50,000 2.00 100,000
2006-08-06 Mckinley Edward J (Director) Buy 1,300 17.59 22,867
2006-06-09 Blair James C (Director) Buy 31,600 17.71 559,636
2006-06-08 Mckinley Edward J (Director) Buy 14,700 17.60 258,778
2006-05-04 Blair James C (Director) Buy 285,200 19.98 5,698,296
2006-05-03 Blair James C (Director) Buy 500,000 18.64 9,320,000
2006-05-02 Blair James C (Director) Buy 103,000 19.01 1,958,030
2006-05-01 Mckinley Edward J (Director) Buy 12,000 19.06 228,719
2006-05-01 Blair James C (Director) Buy 111,800 19.03 2,127,554
2006-03-03 Mckinley Edward J (Director) Buy 34,000 17.11 578,726
2006-03-03 Hemberger Judith A (Exec VP and COO) Sale 21,666 16.90 366,112
2006-03-02 Mahaffy Patrick J (President and CEO) Buy 5,882 17.01 100,052
2006-02-24 Mast Erle T (Executive VP and CFO) Buy 1,500 15.50 23,250
2005-12-13 Ivers-read Gillian C (Vice President) Sale 7,650 18.44 141,035
2005-11-01 Hemberger Judith A (Exec VP and COO) Sale 50,000 18.47 923,349
2005-10-28 Mckinley Edward J (Director) Buy 20,000 17.57 351,420
2005-10-28 Mast Erle T (Chief Financial Officer) Buy 2,000 17.58 35,170

Insider trading activities including stock purchases, stock sales, and option exercises of PHRM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pharmion Corp (symbol PHRM, CIK number 1203866) see the Securities and Exchange Commission (SEC) website.